Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
ZG-802 by Zeria Pharmaceutical for Hypoactive Bladder: Likelihood of Approval
ZG-802 is under clinical development by Zeria Pharmaceutical and currently in Phase II for Hypoactive Bladder. According to GlobalData, Phase...